Stay updated on JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial

Sign up to get notified when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:29:08.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a potential update in the efficacy evaluation of JNJ-42165279 compared with placebo in treating symptoms of Autism Spectrum Disorder (ASD) during a 12-week treatment period.
    Difference
    0.1%
    Check dated 2024-06-06T14:30:29.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifically focusing on the diagnosis of Autism Spectrum Disorder (ASD) according to DSM-5 criteria. Previously, this section had no information provided.
    Difference
    27%
    Check dated 2024-05-22T20:25:59.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:14:51.000Z thumbnail image

Stay in the know with updates to JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial

Enter your email address, and we'll notify you when there's something new on the JNJ-42165279 in ASD: Efficacy, Safety, Tolerability Clinical Trial page.